ellipticine has been researched along with Cancer of Liver in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Abreu, RM; Adega, F; Calhelha, RC; Chaves, R; Ferreira, IC; Lima, RT; Queiroz, MJ; Vasconcelos, MH | 1 |
| Cho, CY; Hsu, YL; Kuo, PL; Kuo, YC; Lin, CC | 1 |
2 other study(ies) available for ellipticine and Cancer of Liver
| Article | Year |
|---|---|
Anti-hepatocellular carcinoma activity using human HepG2 cells and hepatotoxicity of 6-substituted methyl 3-aminothieno[3,2-b]pyridine-2-carboxylate derivatives: in vitro evaluation, cell cycle analysis and QSAR studies.
Topics: Animals; Antineoplastic Agents; Carboxylic Acids; Carcinoma, Hepatocellular; Cell Cycle; Cell Proliferation; Cells, Cultured; Hep G2 Cells; Humans; Liver; Liver Neoplasms; Pyridines; Quantitative Structure-Activity Relationship; Swine | 2011 |
Ellipticine induces apoptosis through p53-dependent pathway in human hepatocellular carcinoma HepG2 cells.
Topics: Antineoplastic Agents; Apoptosis; Carcinoma, Hepatocellular; Cell Line, Tumor; Cell Proliferation; DNA; DNA Fragmentation; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Ellipticines; Fas Ligand Protein; fas Receptor; Humans; Liver Neoplasms; Membrane Glycoproteins; Membrane Potentials; Mitochondria, Liver; Mitochondrial Membranes; Plant Extracts; Proto-Oncogene Proteins c-bcl-2; Tumor Necrosis Factors; Tumor Suppressor Protein p53; Up-Regulation | 2006 |